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A B S T R A C T
Objective: To investigate GABA-ergic receptor density and associated brain functional and grey matter changes
in focal hand dystonia (FHD).
Methods: 18 patients with FHD of the right hand and 18 age and gender matched healthy volunteers (HV)
participated in this study. We measured the density of GABA-A receptors using [11C] Flumazenil and perfusion
using [15O] H2O. Anatomical images were also used to measure grey matter volume with voxel-based mor-
phometry (VBM).
Results: In FHD patients compared to HV, the vermis VI of the right cerebellum and the left sensorimotor cortex
had a decrease of Flumazenil binding potential (FMZ-BP), whereas the striatum and the lateral cerebellum did
not show signiﬁcant change. Bilateral inferior prefrontal cortex had increased FMZ-BP and an increase of per-
fusion, which correlated negatively with disease duration. Only the left sensorimotor cortex showed a decrease
of grey matter volume.
Interpretation: Impairments of GABAergic neurotransmission in the cerebellum and the sensorimotor cortical
areas could explain diﬀerent aspects of loss of inhibitory control in FHD, the former being involved in mala-
daptive plasticity, the latter in surround inhibition. Reorganization of the inferior prefrontal cortices, part of the
associative network, might be compensatory for the loss of inhibitory control in sensorimotor circuits. These
ﬁndings suggest that cerebellar and cerebral GABAergic abnormalities could play a role in the functional im-
balance of striato-cerebello-cortical loops in dystonia.
1. Introduction
Focal hand dystonia (FHD) is clinically characterized by involuntary
muscular co-contraction causing incoordination and abnormal pos-
turing of the hand during skillful movements that are over-trained. A
common hypothesis to explain the pathophysiology of FHD is a re-
duction of inhibitory control over the cortical motor areas that would
cause sustained muscle contraction (Beck and Hallett, 2011; Hallett,
2011; Marsden, 1995; Mink, 2003). Yet, there is at present no direct
demonstration of what would cause such a phenomenon. In this study,
we seek to better understand the pathophysiology of inhibitory control
in FHD.
Inhibitory control in the human brain is achieved through the
neurotransmitter gamma-aminobutyric acid (GABA). Pharmacological
work using Flumazenil, a benzodiazepine antagonist that binds to
GABA-A receptors, showed GABAergic impairments in the thalamus
and the cerebellum in animal models of dystonia (Ledoux and Lorden,
2002; Zhang et al., 2011; Zhao et al., 2011). GABAergic dysfunctions in
the striatum and the cerebellum have been suggested in FHD (Ceballos-
Baumann et al., 1995a; Krystkowiak et al., 1998; Lehéricy et al., 1996;
Shakkottai et al., 2016). A ﬂumazenil study found GABAergic deﬁcits in
the sensorimotor cortex but none in the cerebellum and putamen in
dystonic patients (Garibotto et al., 2011). A majority of the patients in
this study had DYT1 dystonia and all had impairments aﬀecting several
body parts except for two with focal dystonia. DYT1 dystonia diﬀers
from FHD, which is typically sporadic, acquired after intensive and
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repetitive motor practice, and aﬀects a speciﬁc type of skillful hand
movements.
GABAergic neuromodulation is involved in the ﬁne tuning of brain
networks (Popa et al., 2013). It is conceivable that altered GABAergic
neuromodulation would be associated with functional abnormalities in
the sensorimotor network. For instance, FHD patients are known to
have functional impairments in the primary and secondary motor cor-
tices, in the striatum and cerebellum (Wu et al., 2010; Butz et al., 2006;
Garraux et al., 2004). Task-related activation studies cannot easily
isolate functional changes primarily related to the disease, because they
often involve groups with diﬀerent motor performances or task-induced
compensatory mechanisms. Resting state represents a useful tool to
isolate disease-related changes, and abnormal resting state activity has
been observed in striato-cortical and the cerebello-cortical loops in FHD
(Dresel et al., 2014; Hinkley et al., 2013). In addition to functional
changes, GABAergic deﬁcits in sensorimotor areas could be associated
with structural changes as already found in this patient population
(Delmaire et al., 2007; Gibb et al., 1992). Loss of grey matter volume in
areas showing GABAergic deﬁcits would suggest that abnormal in-
hibitory control could be related to neuronal loss.
In a homogeneous patient population of FHD with focal symptoms
in the right dominant hand and matching healthy controls, we used a
multimodal imaging protocol including (1) Positron Emission
Tomography (PET) with ﬂumazenil binding; (2) PET with [15O]-H2O to
investigate cerebral activation of brain areas with abnormal GABAergic
receptor density; and (3) MRI voxel-based morphometry to verify
whether areas with abnormal GABAergic receptor density would have
abnormal grey matter volume. We hypothesize that the functional im-
balance of striato-cerebello-cortical loops are due to decreases in in-
hibition in the contralateral striatum, contralateral sensorimotor cortex,
and the ipsilateral cerebellum.
2. Methods
2.1. Subjects
We studied eighteen patients with focal hand dystonia and eighteen
healthy volunteers. Patient ages ranged from 24 to 65 years (3 women,
15 men; mean age ± standard deviation = 53.94 ± 12.04 years);
eighteen control subjects were matched for age from 22 to 65 years and
sex (3 women, 15 men; mean age ± standard deviation = 53.29 ±
12.79 years). All subjects had normal neurologic examinations apart
from FHD diagnosis in the patient group. The duration of FHD ranged
from 3 to 41 years (mean ± standard deviation = 13.8 ± 9 years).
All patients were also evaluated with the Fahn-Marsden scale (FMS,
score range from 2 to 4) to assess for the severity and speciﬁcity (re-
stricted to the hand) of symptoms. Patients who participated in the
study did not present any symptoms at rest so that there was no in-
terference with the scanning procedure. Patients were oﬀ any medica-
tion aﬀecting the central nervous system during the study and for at
least 3 months before the study. Speciﬁcally, none of the subjects were
on benzodiazepine medication, which binds GABA-A receptors and
competes directly with ﬂumazenil for binding; baclofen which binds
GABA-B receptors; ﬂunitrazepam, a benzodiazepine receptor agonist; or
triazolam, a partial allosteric modulator of GABA-A receptors. All pa-
tients had their last injection of botulinum toxin (BoNT) at least
3 months before the study. The study was approved by the Institutional
Review Board of the National Institutes of Health. All participants gave
their informed consent.
2.2. MRI and PET procedures
For all subjects, high-resolution structural T1-weighted images were
acquired for anatomical co-registration with a 3 T GE scanner (9 min,
TR = 6.172 ms, TE = 3.2 ms, slice thickness = 1.3 mm, no gap,
FOV = 240 × 240 mm2, 256 × 256 matrix, in-plane
resolution = 0.9375 × 0.9375 mm2). For the PET scan acquisition,
participants were scanned using a General Electric Advance Scanner
(GE Medical Systems, Waukesha, WI). Images were acquired in axial
order (FOV = 150 × 150 mm2, 35 contiguous slices were acquired,
plane separation = 4.25 mm; spatial resolution of raw PET images was
6 to 7 mm full width at half maximum (FWHM)). An 8-min transmission
scan for attenuation correction was obtained at the beginning of the
session (see Lerner et al., 2007; Lerner et al., 2012). Subject motion
during the PET acquisition was corrected with mutual-information re-
gistration of each scan timeframe to a standard frame before attenua-
tion correction (Andersson et al., 1995). Based on the calculated mo-
tion, the transmission images were resliced and projected for ﬁnal
reconstruction and realignment (matrix size of 256 × 256 matrix, in
plane resolution = 2 × 2 mm2). To minimize head movements during
the scans, an individually molded thermoplastic mask was placed on
the face and head of each subject. Subjects were instructed to lie still
while relaxing with their eyes closed, to think of nothing in particular
and not to fall asleep. The entire duration of the PET procedures was
two hours, one hour for [15O] H2O to measure regional cerebral blood
ﬂow (rCBF), and one hour for ﬂumazenil to measure GABA-A receptors.
During the ﬁrst hour, all subjects received 5 intravenous boluses of
10 mCi of [15O] H2O at 10-minute intervals. The distribution of cerebral
radioactivity was measured in a 60-second emission scan after each
bolus injection. No arterial line was inserted because of the equivalence
in errors in measuring tissue radioactivity and in the calculated rCBF
(Herscovitch et al., 1983; Lerner et al., 2007; Lerner et al., 2012).
During the second hour, and after the injection of 20 mCi of [11C]
ﬂumazenil, 60-min dynamic emission images of the brain were ac-
quired.
2.3. Data analysis
2.3.1. PET
Binding potential images for ﬂumazenil (FMZ-BP) were created
using the 2-step version of the simpliﬁed reference tissue model
(SRTM2) (Wu and Carson, 2002). The input kinetics for the reference
tissue were derived from the pons (drawn on each individual's MR
image), where the [11C] ﬂumazenil binding is predominantly accounted
for by free and non-speciﬁcally bound radiotracer (Lerner et al., 2007;
Lerner et al., 2012; Millet et al., 2002; Odano et al., 2009). FMZ-BP
images were corrected for partial volume eﬀects and grey-white matter
ratios on a pixel by pixel basis (Giovacchini et al., 2005). FMZ-BP
images (already transformed to MR space) were normalized to the
standard Montreal Neurological Institute (MNI) PET template
(Ashburner and Friston, 1999) using AFNI (http://afni.nimh.nih.gov/
afni, Bethesda, MD), smoothed (FWHM of 10 mm) and analyzed using
SPM8 (Wellcome Department of Imaging Neuroscience, UCL, London,
UK; http://www.ﬁl.ion.ucl.ac.uk/spm/) implemented in Matlab
(Mathworks Inc., Natick, MA). To test our hypothesis, a between group
analysis was performed (2 sample t-test) to show the brain areas that
had a decrease or an increase of FMZ-BP in patients when compared
with healthy subjects at the level of the whole brain. Age and sex were
included in this analysis as nuisance covariates. An additional region of
interest (ROI) analysis was run for contralateral striatal (putamen and
caudate nuclei) regions involved in sensorimotor functions using the a-
priori masks of the YEB atlas normalized in MNI space (Lehéricy et al.,
2006), and ipsilateral cerebellar lobules V,VI and VIII containing a re-
presentation of the hand (Schmahmann et al., 1999; Küper et al., 2012;
Schlerf et al., 2010).
The image processing and analysis of resting state rCBF levels were
performed using Statistical Parametric Mapping SPM8. The images
were realigned to the ﬁrst volume. The resliced volumes were nor-
malized to a standard PET template based on the MNI reference brain in
MNI space (Talairach and Tournoux, 1988). Additionally, we used an
atlas for the cerebellum (Schmahmann et al., 1999) for the spatial lo-
calization of the clusters. The normalized images of 2 ∗ 2 ∗ 2 mm3
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voxels were smoothed with 10 mm FWHM isotropic Gaussian kernel.
Global CBF was adjusted to an arbitrary value of 50 (Lerner et al.,
2007); an eﬀect of the diﬀerent global CBF values in diﬀerent scans was
removed by analysis of covariance. A summed PET image (0–10 minute
post-injection) was registered to each subject's MRI with a mutual in-
formation algorithm and all the PET images were resliced (for more
details, see Lerner et al., 2007). We performed a between group analysis
(2 sample t-test) to show the brain areas that were overactive or un-
deractive in patients when compared with healthy subjects at rest.
Second, a regression analysis was performed for the patients to test for
possible correlation between individual measures of perfusion and
disease duration. Age and sex were incorporated in the design matrix of
the regression analysis to remove the variance percentage related to
variables of non interest that could interfere with the correlation.
After veriﬁcation of the normality of data distribution, Pearson
correlation was performed between FMZ-BP values and rCBF levels in
regions showing a group diﬀerence in each previous analysis. Data were
extracted averaging the signal in all the voxels included in the sig-
niﬁcant cluster from the previous group analyses. Since there were
several rCBF measures and a single FMZ value per subject, the p-values
were adjusted for multiple comparisons using the permutations test
(Nichols and Holmes, 2002). We conducted an approximate multi-
variate permutation test. At each iteration, the max-correlation coeﬃ-
cient was computed to build the sampling distribution. Using this dis-
tribution, the corrected p-value was calculated for each correlation
coeﬃcient.
2.3.2. Voxel-based morphometry
Images were processed using the VBM8 toolbox (http://dbm.neuro.
uni-jena.de/vbm/), of the SPM8 software. Normalized grey matter
probability maps were obtained from the T1-weighted images. The
processing included denoising (Manjón et al., 2010), partial volume
estimation (Tohka et al., 2004) and normalization to the MNI space
using Dartel (Ashburner and Friston, 2005). The normalized maps were
smoothed with a 10 mm FWHM Gaussian kernel.
In the statistical analysis, the individual smoothed-normalized maps
were included in a two-sample t-test to perform a group comparison.
Age and sex were incorporated in the design matrix to remove the
variance percentage related to variables of non-interest that could in-
terfere with group diﬀerences. We tested the possible correlation be-
tween grey matter volume and individual values of FMZ-BP in areas
showing an eﬀect of group in the PET FMZ-BP and the VBM analyses.
To do that, we extracted the individual FMZ-BP values in the region of
interest (average of all the voxels included in cluster showing a decrease
of BP-FMZ in FHD patients for the group analysis) and, within the same
region of interest, the individual mean values of grey matter probability
maps. For each region of interest, a Pearson correlation was performed
(after veriﬁcation of the normality of data distribution) between in-
dividual FMZ-BP values and individual mean values of grey matter
probability maps (threshold of signiﬁcance at p < 0.05 corrected for
multiple comparisons if needed).
2.3.3. Statistical threshold
We had strong a priori hypotheses on small anatomical regions such
as the hand area of the sensorimotor cortex with high inter-individual
Fig. 1. Results of the two-sample t-test showing the spatial localization of clusters with group diﬀerence in ﬂumazenil binding potential (FMZ-BP) (p < 0.05, FWE correction at the
cluster level). A. Lower ﬂumazenil binding potential in FHD patients compared to controls displayed on a glass brain (upper central view). Clusters localized in the left sensorimotor
cortex, and the vermis of the cerebellum are displayed on the canonical brain of SPM. The results of the ROI analysis including the left putamen and the right cerebellar hemisphere
(lobule VI) are displayed on the right. B. higher ﬂumazenil binding potential in FHD patients compared to controls displayed on a glass brain (upper view). Clusters localized in the
inferior frontal gyri are displayed on the canonical brain of SPM (lower views).
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spatial variability (Yousry et al., 1997). Thus, all the results (FMZ-BP,
rCBF and VBM) were considered signiﬁcant at a statistical threshold of
p < 0.001 uncorrected at the level of the whole brain (Boecker et al.,
2010) with a cluster threshold of 50 contiguous voxels, and at
p < 0.05 with family wise error (FWE) correction for multiple com-
parisons at the level of the cluster. For the region of interest analysis
involving the contralateral sensorimotor territory of the putamen and
caudate, and the ipsilateral sensorimotor lobules of the cerebellum (V,
VI, VIII), the results were considered signiﬁcant at a statistical threshold
of p < 0.05 with family wise error (FWE) correction for multiple
comparisons for the number of considered regions (n = 5).
3. Results
3.1. PET FMZ-BP
At the whole-brain level, the two-sample t-test showed that patients
had a decrease of FMZ-BP in the left dorsal part of the precentral gyrus
(PMd), the primary sensorimotor cortex (including the hand area), the
left anterior insula, the bilateral vermis VI of the cerebellum (more on
the right than on the left; Fig. 1A, Table 1). In the inverse contrast (i.e.
HV-FHD), patients showed an increase of FMZ-BP in the bilateral in-
ferior ventral prefrontal cortex compared to controls (Brodmann area
44, 45, 47; Fig. 1B, Table 1).
At the ROI level, the two-sample t-test showed that patients had a
tendency toward a decrease of FMZ-BP in the left sensorimotor territory
of the putamen (T = 2.01, p = 0.04 uncorrected for multiple compar-
isons), and in the sensorimotor territory of the cerebellar lobule VI
(T = 1.71, p = 0.04 uncorrected for multiple comparisons). These ROI
results did not survive the correction for multiple comparisons.
3.2. PET rCBF
Patients, compared with the healthy volunteers, showed an increase
of resting state rCBF in the bilateral inferior and middle frontal gyri
(Brodmann area 44, 45, 47), in the orbitofrontal cortex, the anterior
cingulate cortex, the right caudate head and the right ventro-anterior
part of the putamen. Results are displayed in Fig. 2A and listed in
Table 1. Regions showing both an increased FMZ-BP and resting state
rCBF are shown in Fig. 2B. Only the left inferior frontal gyrus over-
lapped in the two modalities. The increase of resting state rCBF in the
left inferior frontal gyrus negatively correlated with the FMZ-BP in the
right cerebellar vermis and with disease duration (Fig. 2C–D). Such
correlation was not observed with the cluster of the sensorimotor
cortex, the sensorimotor putamen or the cerebellar lobule VI
(0.28 < p < 0.47).
3.3. VBM
The regions showing diﬀerence of binding potential were deﬁned as
regions of interest for the VBM analysis. Only the left sensorimotor
cortex corresponding to the hand area and the PMd showed a decrease
of grey matter volume (see Fig. 3A). In the sensorimotor cortex, we
observed a trend suggesting that the decrease of grey matter volume
correlated with the decrease of FMZ-BP (Fig. 3B). None of the other
areas with abnormal FMZ-BP had a signiﬁcant group diﬀerence in grey
matter volume (p > 0.001 uncorrected for multiple comparisons at the
level of the whole brain).
4. Discussion
In a patient population with focal right hand dystonia, we veriﬁed
our hypotheses of an abnormal decrease of GABA-A receptor density in
the vermis VI of the right cerebellum and in the left sensorimotor
cortex. Bilateral inferior prefrontal cortex had an increase in FMZ-BP
and of resting state activity, which correlated negatively with disease
duration and the loss of GABA-A receptor density in the cerebellum.
Decrease of FMZ-BP in the sensorimotor cortex was accompanied with
decrease of grey matter volume, but this was not the case for the cer-
ebellar vermis. These ﬁndings seem to indicate that in FHD, the loss of
inhibitory control in sensorimotor areas originate in GABA-ergic ab-
normalities. The loss of inhibitory control is accompanied by cortical
reorganization involving the inferior frontal gyrus. These results re-
inforce the view that despite focal motor symptoms, the pathophy-
siology of dystonia engages changes in larger associative cortical net-
works.
Several mechanisms could explain the decrease of GABAergic re-
ceptor density in the sensorimotor network: (i) a loss of cells with
GABA-A receptors; (ii) decreased number of receptors on the same
number of cells; (iii) an identical number of GABAergic receptors but a
dysfunctional binding site. In our study, there was a decrease of grey
matter volume at the site of decreased FMZ-BP in the sensorimotor
cortex conﬁrming the ﬁndings of another study (Delmaire et al., 2007),
suggesting neuronal loss. This cell loss was however not observed at the
Table 1
Anatomical localization of clusters showing group diﬀerence in ﬂumazenil binding po-
tential displayed in Fig. 1, and in O15water displayed in Fig. 2. MNI = Montreal Neu-
rological Institute, Ke = number of voxels in the cluster, BA = Brodmann area, L = left,
R = right, B = bilateral. Italic font refers to the result of the region of interest analysis
(ROI).
Anatomical localization MNI coordinates of cluster
local maxima
T score Ke
x y z
FMZ-BP: Patients < healthy volunteers
L precuneus (BA 7, 31) −18 −62 32 3.73 207
L paracentral lobule (BA 5),
postcentral gyrus (BA 3),
precentral gyrus (BA 4, 6)
(cluster extension in the hand
area of the primary motor
cortex)
−14 −38 56 3.35 189
−22 −25 58 3.31
L insula, inferior frontal operculum −26 32 10 3.20 514
L cerebellum (vermis 6, fastigium) −2 −62 −24 3.05 88
R inferior frontal operculum, inferior
frontal gyrus
28 34 12 3.02 156
L cerebellum (lobule 3) −6 −42 −22 2.92 97
R cerebellum (Crus 1) 16 −76 −30 2.81 133
L sensorimotor putamen (ROI analysis) −21 −2 9 2.01 34
FMZ-BP: Patients > healthy volunteers
L inferior frontal gyrus (BA 45, 46,
47)
−50 24 −8 4.40 527
R inferior frontal gyrus (BA 45, 46,
47)
58 26 6 3.93 477
O15water: Patients > healthy volunteers
R middle frontal gyrus 46 48 30 8.17 407
R inferior postcentral gyrus,
Rolandic operculum (BA 43)
68 −16 18 8.00 270
B medial orbitofrontal cortex (BA
10)
8 68 −4 7.76 786
R superior orbitofrontal cortex (BA
11)
16 30 −22 7.47 1410
R anterior cingulate cortex (BA 24) 4 32 6 6.66
R anterior putamen and caudate 24 12 −2 6.53
L middle frontal gyrus −38 48 30 5.70 251
R inferior frontal gyrus (operculum,
pars triangularis), superior
temporal sulcus
60 14 2 6.58 505
L anterior caudate −14 18 0 6.55 207
L inferior frontal gyrus (pars
triangularis)
−44 32 −14 6.08 652
L middle frontal gyrus (BA 8) −44 24 20 6.04 366
L middle temporal pole (BA 38) −52 14 −30 5.87 132
VBM: Patients < healthy volunteers
L precentral gyrus (BA 6, PMd) −28 15 50 3.41 241
L postcentral gyrus (BA 2, 3) −20 −44 77 3.08 274
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Fig. 2. Results of group comparison of rCBF PET and correlation analyses. A. Inferior prefrontal cortex, and caudate show an increase of rCBF in FHD patients compared to healthy
controls (p < 0.05 with FWE correction over the whole brain). B. Overlap of areas showing an increase of rCBF and an increase of FMZ-BP, involving only the left prefrontal cortex. C.
Correlation between rCBF in the left inferior prefrontal cortex and the FMZ-BP in the right cerebellar vermis (p = 0.004, Rho =−0.54). D. Correlation between rCBF in the left inferior
prefrontal cortex and the disease duration (p = 0.01, Rho =−0.46). The signiﬁcance of the correlation takes into account repeated measures (see Methods).
Fig. 3. Results of VBM analysis in regions of interest. A. Decrease of grey matter volume in the precentral gyrus, located in the dorsal premotor cortex (left panels) and the postcentral
gyrus (right panels); p < 0.001, with FWE correction at the level of the cluster. B. In the left sensorimotor cortex, individual values of grey matter volume tended to correlate with
individual values of BP-FMZ (p = 0.06, Rho = 0.46).
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site of the right cerebellar vermis. The absence of change in grey matter
volume at that location of GABA-ergic abnormalities however does not
preclude the possibility of abnormal morphology. Indeed, synaptic loss
or dendritic transections are not fully captured by VBM analyses be-
cause of special sensitivity limitations. Moreover, our sample size might
be not large enough to detect morphometric changes. This, together
with diﬀerences in methodology or patient phenotypes, explain the
discrepancy found concerning changes of grey matter volume in the
primary sensorimotor cortex and the cerebellum, which some found
increased (Ramdhani et al., 2014; Garraux et al., 2004), or decreased
(Delmaire et al., 2007) or unchanged (Zeuner et al., 2015). Thus, a
decrease in the number of GABA-A receptors due to a reduced synthesis
of GABA neurotransmitter cannot be ruled out. Indeed, decreased GABA
levels were measured in the primary motor cortex of FHD patients
compared to control subjects using MR spectroscopy (Levy and Hallett,
2002), although another study failed to conﬁrm it (Herath et al., 2010).
Decreases of FMZ-BP could also be due to excessive GABA synthesis
which would cause more competition with ﬂumazenil in the synaptic
cleft. In that case, it would have to be associated with a dysfunctional
binding site.
The reduced grey matter volume and the decrease of FMZ-BP are
likely associated with the loss of GABAergic neurons in sensorimotor
cortices involved in controlling the symptomatic hand. GABA-ergic
abnormalities in the sensorimotor cortex might relate to impairment of
speciﬁc neurons with somatotopic representations. Previous studies
have reported that FHD patients showed somatotopic disorganization in
the motor cortex (Weise et al., 2011; Meunier et al., 2001; Nelson et al.,
2009). We suggest that a decrease of GABAergic function within M1
and S1 could underlie the changes of somatotopic representation by a
larger spread of neuronal excitation. In healthy volunteers, high fre-
quency repetitive somatosensory stimulation modulates short in-
tracortical inhibition within M1 (Rocchi et al., 2017), mediated by G-
ABA-A interneurons (Chen, 2004). Short intracortical inhibition within
M1 or between PMd and M1 is reduced in FHD (Currà et al., 2000;
Tinazzi et al., 2000; Beck and Hallett, 2011), and interpreted as a loss of
surround inhibition. The loss of GABA-A neurons in the sensorimotor
cortex could contribute to abnormal interactions between sensory and
motor areas, supporting the loss of surround inhibition and the patients'
inability to perform individuated ﬁnger movement (Moore et al., 2012).
To validate this hypothesis, future multimodal studies will have to test
whether the individual GABA-A binding potential in the sensorimotor
cortex would be related to individual values of short intracortical in-
hibition in M1.
FMZ-BP in the cerebellum was not found to be abnormal in the
previously reported patient population including DYT1 and sporadic
dystonia, with symptoms in multiple limbs (Garibotto et al., 2011). Our
patient population with homogeneous and focal symptoms aﬀecting the
right dominant hand had focal GABA-ergic impairments of the cere-
bellar vermis. The cerebellar vermis is connected to cortical motor areas
and would participate in controlling the anticipatory postural adjust-
ments during hand movement initiation (Diedrichsen et al., 2005). It
was speculated that dysfunction of this system may underlie abnormal
postural control in dystonia (Coﬀman et al., 2011). Recently, an ab-
stract report of patients with cervical dystonia showed decreased GABA
binding in the cerebellar vermis and the dorsal premotor cortex (Pollard
et al., 2016), conﬁrming that this network is relevant for focal dystonia.
In accordance with our ﬁndings, the cerebellar vermis is also a relevant
site to explain dystonic symptoms since microinjection of kainic acid
into this structure generates dystonia in mice (Pizoli et al., 2002).
The cerebellum may be one of the primary nodes underlying dys-
tonia (Shakkottai et al., 2016). If that is the case, how would the loss of
inhibitory control in the cerebellum aﬀect the cerebello-cortical loop
and be related to dystonic symptoms? Defective GABA-ergic neuro-
transmission in the cerebellum could induce abnormal cerebello-cor-
tical dialog, particularly in the gamma frequency band, and explain
abnormal muscular activity. For instance, blockade or inactivation of
GABA-ergic neurons of the cerebellum abolishes or decreases gamma
rhythms of cerebellar output and of the sensorimotor cortex (Popa
et al., 2013; Middleton et al., 2008). The integrity of the GABAergic
system also inﬂuences neuroplasticity mechanisms, for example in long
term potentiation (LTP) of synaptic eﬃcacy (Stefan et al., 2000; Wolters
et al., 2003). Patients with FHD have over-reactive LTP-like plasticity
(Quartarone et al., 2003), and cerebellar stimulation fails to induce
plastic modulation of M1 in this patient population (Hubsch et al.,
2013). We suggest that the loss of cerebellar modulation of M1 prob-
ably originates in the loss of GABAergic cells in the sensorimotor net-
work.
Neumann et al. (2015) found that the degree of pallido-cerebellar
coupling, in the sense that GPi drove the activity of the cerebellum,
showed an inverse correlation with dystonic symptom severity. This
suggests that striatal dysfunction impacts on cerebellar activation, re-
ducing the communication in striato-cerebellar circuits as disease se-
verity increases. Whether the resulting cerebellar output is adaptive or
maladaptive is diﬃcult to say with certainty at this point. Variations of
cerebellar-cortical functional connectivity at rest could reﬂect both an
underlying abnormality or compensatory neuroplastic changes of net-
work architecture in focal hand dystonia (Dresel et al., 2014). A com-
pensatory role of the left cerebellar cortex (CrusI) was found during
motor sequence learning in DYT1 mutation carriers (Carbon et al.,
2011), a structure involved in the early phase of motor learning (Doyon
et al., 2003; Floyer-Lea and Matthews, 2005). In the light of these re-
sults, GABAergic changes in associative cerebellar structures such as the
CrusI could be compensatory or adaptative.
Increased resting state activity of prefrontal regions was observed in
our FHD patients. Changes of resting state activity was observed in
previous studies using PET (Ceballos-Baumann and Brooks, 1997;
Ceballos-Baumann et al., 1997; Ceballos-Baumann et al., 1995a, 1995b;
Playford et al., 1998) and fMRI (Bharath et al., 2015; Dresel et al.,
2014; Delnooz et al., 2013). In genetic dystonia, increased activation in
the inferior frontal gyrus cortex was interpreted as compensatory to
sensorimotor loop dysfunction (Carbon et al., 2004; Nakamura et al.,
2001). Our results seem to favor this view for FHD: inferior prefrontal
cortex has increased GABA-ergic neurotransmission, which correlated
negatively with GABA-ergic neurotransmission in the cerebellar vermis
and with disease duration. The relationship between GABA-ergic
function and dystonic symptoms suggests the existence of plastic
changes with time in the inferior frontal gyrus. These ﬁndings are in-
triguing because, despite the focal symptoms, they suggest the existence
of complex regulatory systems involving larger networks than the ones
involved in sensorimotor integration. The variability of disease severity
was small in our patients, which could be a reason why we did not ﬁnd
a correlation with symptom severity. The inferior frontal gyrus is in-
volved in building sensorimotor schemes to adapt ﬁnger conﬁguration
during grasping tasks (Jeannerod et al., 1995). This area is also in-
volved in the prevention of unwanted movement by ‘calling out’ or
compensating for motor areas responsible for the ﬁnal motor output
(Duann et al., 2009; Obeso et al., 2013; Sharp et al., 2010; Swick et al.,
2008). Our study raises further evidence that local neurotransmitter
contents like GABA relate to functional specialization of brain regions
(Greenhouse et al., 2016), which are abnormal in FHD (Gallea et al.,
2016).
This study has several limitations. For instance, we found only a
tendency toward GABA-ergic abnormalities in the striatum, despite the
well-known striatal alterations in this disorder (Marsden et al., 1985;
Delmaire et al., 2009; Delnooz et al., 2013). It is also possible that
cerebellar interactions with the striatum contribute to the dystonic
symptoms through other neurotransmitters. Cerebellar activity can di-
rectly inﬂuence the dynamics of striatal dopamine (Neychev et al.,
2008), and it is known that FHD has striatal dopaminergic impairments
(Berman et al., 2013; Karimi et al., 2011). Another limitation is the lack
of serial blood sampling for plasma input function to ﬁt compartmental
models. However, the modelling technique used in the present study
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allows quantifying BP using a reference tissue in which no speciﬁc
binding of the radioligand occurs, without arterial blood sampling
(Lerner et al., 2012). The individual values of BP in the regions of in-
terest were normalized with the BP of the pons, which also cancelled
out the inﬂuence of individual level of blood concentration. Therefore,
the correlations between FMZ-BP and rCBF seem to be likely related to
the functional relationship between the changes of GABAergic neuro-
transmission and perfusion. Last, correlation between symptom severity
and FMZ-BP or rCBF could not be evaluated due to the lack of sensi-
tivity of the Burke-Fahn-Marsden scale to task-speciﬁc focal hand dys-
tonia and resulted in a narrow range of scores.
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